About GutCRINE
"Changing the paradigm for prevention and treatment of cardio-metabolic disorders by pioneering the first-of-its-kind pharmabiotics derived from gut microbiome hormone synthesis"
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Undisclosed
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
gutcrine.dk
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Seed announced
fundraisingfox.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for GutCRINE.
Funding History
Seed
· Jun 12, 2023
Undisclosed fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026